45 drug-nutrient interactions (DNIs) that modify micro-nutritional status, particularly focusing on how acetylsalicylic acid (ASA) and warfarin may affect patients through various mechanisms.
HH-006 by Huahui Health for Hepatitis D: Likelihood of Approval
HH-006 is under clinical development by Huahui Health and currently in Phase I for Hepatitis D.